T4 is one of the Eternal Brands of Greece. 

As one of the ETERNAL BRANDS of our country, the T4 formulation of the pharmaceutical industry Uni-pharma was awarded, by a Bronze medal, on Friday, October 23, 2020.

T4 (levothyroxine sodium tablets) is a specialized therapy, aimed at treating thyroid diseases.

The T4 was licensed on July 29, 1981 and production began almost immediately. Today, it is available in 13 individual dosage contents.
It has been approved in 11 countries in the European Union and 7 other countries worldwide from Latin America to Asia and Africa. In detail, the countries in which it has been approved are the following:
Albania, Azerbaijan, Chile, Georgia, Macau, Nepal, Tunisia, Cyprus, Denmark, Finland, France, Iceland, Malta, Netherlands, Poland, Portugal, Spain, Sweden.

The Vice President of the Board of the Tsetis Pharmaceutical Group of Companies Mr. Athanasios Archontikis, received the significant Award, by the Deputy Minister of Development and Investment Mr. Nikos Papathanasis,.